Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy.

MLA

Di Biase, Stefano, et al. “Fasting Regulates EGR1 and Protects from Glucose- and Dexamethasone-Dependent Sensitization to Chemotherapy.” PLoS Biology, vol. 15, no. 3, Mar. 2017, pp. 1–21. EBSCOhost, https://doi.org/10.1371/journal.pbio.2001951.

APA

Di Biase, S., Shim, H. S., Kim, K. H., Vinciguerra, M., Rappa, F., Wei, M., Brandhorst, S., Cappello, F., Mirzaei, H., Lee, C., & Longo, V. D. (2017). Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy. PLoS Biology, 15(3), 1–21. https://doi.org/10.1371/journal.pbio.2001951

Chicago

Di Biase, Stefano, Hong Seok Shim, Kyung Hwa Kim, Manlio Vinciguerra, Francesca Rappa, Min Wei, Sebastian Brandhorst, et al. 2017. “Fasting Regulates EGR1 and Protects from Glucose- and Dexamethasone-Dependent Sensitization to Chemotherapy.” PLoS Biology 15 (3): 1–21. doi:10.1371/journal.pbio.2001951.